Cardiovascular Disease Clinical Research  

Reducing the burden of cardiovascular disease in patients

As a leading life-shortening disease, cardiovascular diseases are critical to prevent and treat immediately in patients around the world. The clinical trial process is complicated and full of unknowns, and even the best cardiovascular therapeutic might not make it to the patients that need it, not because it does not work but because the design, data collection, and analysis were not done right.

At Veristat, we have assembled an extraordinary team of scientific-minded experts who have mastered the complexities of running cardiovascular disease trials. We have supported more than 200 clinical trials for cardiovascular treatments, diagnostics, and medical devices.

Improving Cardiovascular Disease Outcomes Through Expertise

The acute nature of most cardiology/vascular diseases makes them highly complex to treat.  Our diverse trial experience, coupled with our knowledgeable and experienced teams, allows us to confidently handle the most complex trials and patient populations with the attention and focus needed to navigate the cardiology/vascular disease landscape.

At Veristat, our experienced teams are poised to plan and implement these efforts quickly providing:     


> 200

clinical trials supported for Cardiovascular Disorders


> 40%

of these clinical trials are RARE DISORDERS


> 65%

Marketing Applications prepared are approved, to date

Explore Our Recent Cardiology Experience

Driving Successful Outcomes for Cardiovascular Trials
Abdominal Aortic Aneurysm (AAA) 
Ehlers-Danlos Syndrome (EDS) 
Ischemic Heart Disease 
Acute Coronary Syndrome
Electrocardiogram (ECG)
Myocardial Infarction
Acute Hereditary Angioedema Attacks
Blood/Brain Barrier Crossing of Drug
Familial Chylomicronemia Syndrome (FCS)
Raynaud's Disease
Cardiac Fibrosis
Heart Failure
Stroke - Aneurysmal Subarachnoid Hemorrhage (aSAH)
Cardiac Imaging
Hereditary Transthyretin Amyloidosis (hATTR)
Treatment after Creation of Arteriovenous Access for Hemodialysis Use
Coronary Arterial Restenosis
Homozygous Familial Hypercholesterolemia (HoFH)
Vascular Access Graft
Coronary Artery Bypass Grafting (CABG)
Hyperlipoproteinemia(a) and Established Cardiovascular Disease (CVD)
Vascular Ehlers-Danlos Syndrome (EDS)
Coronary Artery Disease
Vascular Injury
Critical Limb Ischemia
Venous Leg Ulcers (VLU)


Learn More with These Resources

Webinar Presentation
Webinar: Virtual Trial Planning Lessons Learned

Get the webinar presentation to see lessons learned and recommendations for designing protocols that enable flexibility in your virtual trials' ...

Case Study
Writing Multiple Marketing Applications At The Same Time

A mid-size pharmaceutical company and its development partner, a small biotechnology company engaged Veristat to complete the medical writing for their product’s ...

Fact Sheet
Cardiovascular Experience Fact Sheet

With Cardiovascular Diseases being the leading cause of death worldwide, Veristat is committed to supporting cardiovascular clinical trials to make a difference in ...

Request A Proposal